Dudediligence.

The Chemours Company

CCNYSE · Chemicals & Allied Products
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$1.51BSep ’24$1.36BDec ’24$1.37BMar ’25$1.61BJun ’25$1.50BSep ’25$1.33BDec ’25$1.38BMar ’26$1.59BJun ’26
Net income, by quarter
−$32.0MSep ’24−$11.0MDec ’24−$5.0MMar ’25−$380.0MJun ’25$46.0MSep ’25−$47.0MDec ’25−$29.0MMar ’26−$274.0MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$6.34B$6.83B$6.08B$5.78B$5.81B
Gross profit$1.38B$1.62B$1.30B$1.14B$902.0M
Net income$608.0M$578.0M−$253.0M$69.0M−$386.0M
Operating cash flow$814.0M$755.0M$556.0M−$633.0M$264.0M
Free cash flow$537.0M$448.0M$186.0M−$993.0M$51.0M
Cash$1.45B$1.10B$1.20B$713.0M$670.0M
Debt$3.75B$3.63B$4.04B$4.11B$4.14B
Shares outstanding161.0M148.5M148.6M149.4M149.9M